SCHEMBL29987697

SCHEMBL29987697

BrCc1cc(Br)cc(Br)n1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24742210 1.00 CCR1 (0.36) CCR1
SCHEMBL842158 0.87 CCR1 (0.40) CCR1
SCHEMBL17212404 0.76 NOS3 (0.38) CCR1
SCHEMBL23694777 0.76 CCR1 (0.33) CCR1
SCHEMBL15630262 0.76 CCR1 (0.33) CCR1
SCHEMBL18320627 0.76 LMNA (0.34) CCR1
SCHEMBL724151 0.74
SCHEMBL29452982 0.72 HTR6 (0.33)
SCHEMBL29988098 0.72 RIPK1 (0.31) CCR1
SCHEMBL22462860 0.72 RIPK1 (0.31) CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022206888-A1 CDK2 INHIBITORS AND USE THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2022-10-06 WO disclosed